Interestingly, CyR‐SS‐L was more efficacious in inhibiting the proliferation of paclitaxel‐resistant breast cancer tumors than ICG by inhibition of ABCB1 and activating the mitochondrial apoptosis pathway with very little toxicity in normal cells due to the intelligent selectivity of PDT. The gene discussed is ABCB1; the disease is breast carcinoma.